Cargando…

Potential Roles of Metals in the Pathogenesis of Pulmonary and Systemic Hypertension

Pulmonary and systemic hypertension (PH, SH) are characterized by vasoconstriction and vascular remodeling resulting in increased vascular resistance and pulmonary/aortic artery pressures. The chronic stress leads to inflammation, oxidative stress, and infiltration by immune cells. Roles of metals i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hopkins, C. Danielle, Wessel, Caitlin, Chen, Oscar, El-Kersh, Karim, Cave, Matthew C., Cai, Lu, Huang, Jiapeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620830/ https://www.ncbi.nlm.nih.gov/pubmed/37928257 http://dx.doi.org/10.7150/ijbs.85590

Ejemplares similares

Metallomics in pulmonary arterial hypertension patients
por: El‐Kersh, Karim, et al.
Publicado: (2023)

Plasma level of antimony correlates with pulmonary arterial hypertension severity
por: El-Kersh, Karim, et al.
Publicado: (2022)

Social determinants of health in pulmonary arterial hypertension patients in the United States: Clinician perspective and health policy implications
por: Nadipelli, Vijay R., et al.
Publicado: (2022)

Transcription factors in the pathogenesis of pulmonary arterial hypertension—Current knowledge and therapeutic potential
por: Körbelin, Jakob, et al.
Publicado: (2023)

Protein trafficking dysfunctions: Role in the pathogenesis of pulmonary arterial hypertension
por: Sehgal, Pravin B., et al.
Publicado: (2011)

Real‐world treatment patterns, healthcare resource utilization, and cost among adults with pulmonary arterial hypertension in the United States
por: Pizzicato, Lia N., et al.
Publicado: (2022)

Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension
por: Ye, Yi, et al.
Publicado: (2023)

Contribution of reactive oxygen species to the pathogenesis of pulmonary arterial hypertension
por: Jernigan, Nikki L., et al.
Publicado: (2017)

Partial anomalous pulmonary venous return: A case series with management approach
por: El-Kersh, Karim, et al.
Publicado: (2019)

Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension
por: Guerreso, Kelsey, et al.
Publicado: (2016)

Epsin15 Homology Domains: Role in the Pathogenesis of Pulmonary Arterial Hypertension
por: Predescu, Dan, et al.
Publicado: (2018)

Pathogenesis of pulmonary arterial hypertension: lessons from cancer
por: Guignabert, Christophe, et al.
Publicado: (2013)

Pathogenesis of pulmonary hypertension caused by left heart disease
por: Xiao, Mingzhu, et al.
Publicado: (2023)

Acute Eosinophilic Pneumonia Associated With COVID-19 Infection
por: Vogel, Derek C, et al.
Publicado: (2022)

Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model
por: Wang, Jie, et al.
Publicado: (2022)

Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease
por: Batton, Kyle A., et al.
Publicado: (2018)

Contemporary insights into the pathogenesis, diagnosis and therapy of pulmonary arterial hypertension
por: Essop, Mohammed R
Publicado: (2010)

High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management
por: Mirrakhimov, Aibek E., et al.
Publicado: (2016)

Focus on Early Events: Pathogenesis of Pulmonary Arterial Hypertension Development
por: Rafikova, Olga, et al.
Publicado: (2019)

Involvement of Low‐Density Lipoprotein Receptor in the Pathogenesis of Pulmonary Hypertension
por: Umar, Soban, et al.
Publicado: (2020)

Epidemiology, Pathogenesis, and Clinical Approach in Group 5 Pulmonary Hypertension
por: Al-Qadi, Mazen, et al.
Publicado: (2021)

Aryl hydrocarbon receptor is essential for the pathogenesis of pulmonary arterial hypertension
por: Masaki, Takeshi, et al.
Publicado: (2021)

MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment
por: Xu, Junhua, et al.
Publicado: (2022)

Targeting the adventitial microenvironment in pulmonary hypertension: A potential approach to therapy that considers epigenetic change
por: Stenmark, Kurt R., et al.
Publicado: (2012)

A Potential Role of Interleukin 10 in COVID-19 Pathogenesis
por: Lu, Ligong, et al.
Publicado: (2021)

Hypoxia-induced alterations in the lung ubiquitin proteasome system during pulmonary hypertension pathogenesis
por: Wade, Brandy E., et al.
Publicado: (2018)

Pulmonary hypertension in stiff left atrial syndrome: pathogenesis and treatment in one
por: Maeder, Micha T., et al.
Publicado: (2017)

Schistosome-Associated Pulmonary Arterial Hypertension: A Review Emphasizing Pathogenesis
por: Ferrari, Teresa Cristina Abreu, et al.
Publicado: (2021)

Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice
por: Zhang, Guangyan, et al.
Publicado: (2022)

Role of Musclin in the Pathogenesis of Hypertension in Rat
por: Li, Ying-Xiao, et al.
Publicado: (2013)

Impact of Quality Improvement on Care of Chronic Obstructive Pulmonary Disease Patients in an Internal Medicine Resident Clinic
por: Burkes, Robert M., et al.
Publicado: (2018)

Impaired NO-cGMP signaling in the pathogenesis of neonatal pulmonary hypertension and therapeutic implications
por: Abman, Steve H
Publicado: (2009)

Copy-number variation in BMPR2 is not associated with the pathogenesis of pulmonary arterial hypertension
por: Johnson, Jennifer A, et al.
Publicado: (2009)

Dysregulation of microRNA-214 and PTEN contributes to the pathogenesis of hypoxic pulmonary hypertension
por: Liu, HaiTao, et al.
Publicado: (2017)

Involvement of PFKFB3 in Pulmonary Arterial Hypertension Pathogenesis. Is It All about Glycolysis?
por: Bonnet, Sebastien, et al.
Publicado: (2019)

New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension
por: Hu, Liqing, et al.
Publicado: (2020)

A multifaceted investigation into molecular associations of chronic thromboembolic pulmonary hypertension pathogenesis
por: Halliday, Stephen J, et al.
Publicado: (2020)

Caught in a vicious cycle: Cell‐free hemoglobin and the pathogenesis of pulmonary hypertension
por: Gonzales, Janae, et al.
Publicado: (2023)

Secrecy and the Pathogenesis of Hypertension
por: Ettner, Randi, et al.
Publicado: (2012)

Antibodies in the Pathogenesis of Hypertension
por: Chan, Christopher T., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6o5uqeq27mqgaubmub70ruroqf